AzTrials
AzTrials

Olecranon FractureNCT03280602

Operative Treatment of Olecranon Fractures

A study testing Tension band wiring (TBW) and Plate fixation in people with Olecranon Fracture, run by Oslo University Hospital at 1 site in Norway.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The incidence of olecranon fractures is 12 per 100.000. Traditionally, isolated olecranon fractures have been treated with tension band wiring (TBW). There is a trend towards increased use of plate fixation, though TBW has yielded good and comparable patient reported outcomes. Read more about this study

Who is it for?
Ages 18 to 75 years
Conditions the study is for
Olecranon Fracture
What is being tested?
Tension band wiring (TBW) and Plate fixation
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
1 siteNorway
Study dates
1 Dec 2017to 1 Sep 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients between the age of 18 and 75 years with an olecranon fracture Mayo type IIA or IIB will be eligible for inclusion.

Who cannot join

  • Patients younger than 18 or older than 75 years of age.
  • Unable to receive oral and written information.
  • Concomitant fracture in the injured extremity.
  • When the olecranon fracture extends distal to the coronoid process.
  • Previous injury or illness in the injured upper extremity with permanent reduced elbow function.

Trial locations and contacts

1 site in 1 country.

Norway1 site
  • Oslo University Hospital

    Oslo, Oslo

Other trials in Norway

About this study

Official title: Randomzied Controlled Trial Comparing Tension Band Wiring and Plate Fixation in the Treatment of Olecranon Fractures in Adults

The incidence of olecranon fractures is 12 per 100.000. Traditionally, isolated olecranon fractures have been treated with tension band wiring (TBW). There is a trend towards increased use of plate fixation, though TBW has yielded good and comparable patient reported outcomes. The latter method is substantially cost-effective, but higher complication reports have been reported. There are only two randomized controlled trials comparing TBW and plate fixation, and the literature is inconclusive in which fixation method is preferable in the treatment of olecranon fractures. In this multi-center trial, adult patients (18-75 years) with isolated olecranon fractures will be randomized to either TBW or plate fixation.

Read the detailed description

Introduction:

The incidence of proximal ulna fractures is 12 per 100.000, and 10 % of all fractures in the upper extremity involve the olecranon. There are several systems classifying olecranon fractures. One of the most frequently used is the Mayo classification system as described by Cabanela and Morrey. Tension band wiring (TBW) is the most common operative technique for the treatment of olecranon fractures, and is said to be the gold standard in the treatment of non-comminuted and minimally comminuted displaced olecranon fractures. Treatment with TBW has shown good clinical results, but due to the thin layer of tissue overlying the proximal ulna, hardware issues are common. The frequency of hardware removal following TBW has been reported as high as 82 %. Only two randomized trials have compared TBW and plate fixation of olecranon fractures. Hume and Wiss compared TBW with one-third tubular plate fixation. The authors found no significant functional differences between the treatment methods, but the rate of symptomatic hardware problems was higher in the group treated with TBW. The authors also noted that loss of reduction was higher in the TBW group at final follow-up (12 months after surgery). Duckworth found no difference in patient reported outcome after one year. The sophistication in plate fixation has evolved since Hume and Wiss published their 25 years ago. The use of locking stable plate fixation in the treatment of olecranon fractures is preferred by many surgeons, especially when treating osteoporotic individuals and in cases with severe fracture fragmentation. Though locking stable implants have shown to improve fragment fixation in biomechanical and cadaveric studies, better patient reported outcome in clinical studies has yet to be proven. It is still unclear if all comminuted fractures should be treated with plate fixation, or if moderately comminuted fractures can be treated with TBW. Hardware related issues following plate fixation have also been described as a frequent problem, and rates of hardware removal up to 56 % have been reported. When approaching the issue of symptomatic hardware problems following TBW and plate fixation, one must take into consideration that the magnitude of secondary surgery is different. The removal of the two K-wires is less extensive than removing an angular stable plate fixation. Removal of symptomatic pin protrusion can be achieved in local anesthesia at the outpatient clinic, whereas plate removal routinely is done in the operating theatre, and usually requires that patient is in regional or general anesthesia. Of course, if the wire cerclage has to be removed in addition to the K-wires, the scope of the procedure is more comparable. There are strong indications that locking plate fixation yield better results when treating severely comminuted olecranon fractures, but the investigators do not know if these modern implants are superior in the treatment of moderately comminuted fractures. Even so, there is a trend toward treating all comminuted olecranon fractures with plate fixation, but the clinical evidence supporting this is limited. The investigators believe there is a need for a robust investigation in the treatment of olecranon fractures to identify the fracture patterns that adequately can be treated with TBW and the ones that should be treated with locking plate fixation.

Study aims:

The investigators want to compare an angular stable plate fixation with TBW in a randomized, controlled multi-center trial. Our hypothesis is that TBW is non-inferior in the treatment of Mayo type IIA and IIB fractures compared with an angular stable implant. The primary outcome measure is the Quick Disability of the Arm, Shoulder and Hand outcome measure (QuickDASH) at 12 months

Study design and methodology:

The study is a randomized, controlled, multicenter trial. Adult patients (18-75 years) admitted with a displaced olecranon fracture in need of surgery will be randomized to either TBW or plate fixation. The design is semi-blinded. At follow-up, an independent investigator will perform an interview and blinded functional examination, followed by an un-blinded examination and interview. Patients will be recruited at the Oslo University Hospital, and other hospitals in the region has been invited to participate in the trial. An experienced trauma surgeon will verify that the fracture meets the inclusion criteria, and the patient will be given thorough oral and written information. After signed consent, the randomization allocation to treatment method will be performed by means of a web-solution made by NTNU WebCRF system with the approval from the OUS Head of Patient Security. To secure an even dispersion in regard to age of the patients and fracture pattern, the inclusion of study patients will be stratified. This will achieve an equal randomization dispersion of patients in in the age interval from 18 to 50 years, and 50 to 75 years. Comminuted and non-comminuted fracture fractures will be randomized in the same fashion.

Power analysis and sample size:

Using the mean value of QuickDASH following olecranon fracture in a similar population, the investigators found the standard deviation (SD) to equal 12 points. The minimal clinical important difference (MCID) has been set to 8 points, and the non-inferiority limit is DASH reduction of 10 points. Level of significance (α) equals 0.05. To prove non-inferiority, a power of 0.90 and with non-inferiority limit at 10, the number required in each group is 39 patients. Taking into account a predicted loss of patients during follow-up, the investigators aim to include at least 45 patients in each group.

Follow-up:

The study patients will be followed-up over a one year period (6 weeks, 12 weeks, 12 months). The rate of hardware removal in both groups will be recorded, and the indication for removal (pain, skin protrusion/wound problems, nerve irritation etc.) will be registered and categorized. All other reoperations will be recorded as well.

Being tested
Tension band wiring (TBW), Plate fixation
Medical subject headings
Olecranon Fracture

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Tension band wiring (TBW)Procedure or surgery

    2 x K-wire fixation (1.6 mm) and wire cerclage.

  • Plate fixationProcedure or surgery

    Olecranon fractures in this arm are fixed with Synthes´ VA-LCP Olecranon Plates 2.7/3.5.

Study groups in NCT03280602
Study groupRoleWhat they receive
Tension band wiring (TBW)Active comparatorTBW following the AO principles with 2 x 1.6 mm K-wires and wire wire cerclage.
Receives: Procedure: Tension band wiring (TBW); Procedure: Plate fixation
Plate fixationActive comparatorPlate fixation with Syntes VA-LCP olecranon plates 2.7/3.5
Receives: Procedure: Tension band wiring (TBW); Procedure: Plate fixation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The Quick Disability of the Arm, Shoulder and Hand Outcome Measure (QuickDASH)

    The QuickDASH questionnaire evaluates difficulty performing specific tasks and symptoms, social and work function, sleep and confidence. Scaling is ranked from 0 indicating least disability to 100 indicating most disability.

    Measured: 12 months

Secondary outcomes (9)
  1. Mayo Elbow Performance Score (MEPS)

    MEPS is the primary outcome parameter. MEPS consist of four categories evaluating pain, range of motion, stability and function.6 The scale ranges from 0 to 100, with higher score indicating better outcome. Pain is weighed highest of the 4 variables. Patient outcome can be categorized into excellent (MEPS > 90), good (MEPS 75-90), fair (MEPS 60-74) and poor (MEPS < 60).

    Measured: 12 months

  2. Grip strength

    A hand dynamometer will be used to measure grip strength in both hands

    Measured: 12 months

  3. Range of motion (ROM)

    A goniometer will be used to register ROM in elbow flexion, extension and rotation.

    Measured: 12 months

  4. The EuroQol five dimensions questionnaire (EQ-5D-5L)

    Health status is measures health status/quality of life into one of five levels for the five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. The data is computed to a number (EQ-Index) ranging from 0-1.00, where 1.00 is the best possible outcome, and negative values describe a status theoretically worse than being dead. In addition, the patients score their overall life quality on a vertical line, directly measured in millimeters as EQ-VAS score (0-100, 100 best).

    Measured: 12 months

  5. Satisfaction with elbow function

    An individual satisfaction assessment will be recorded using a visual analogue scale (VAS) of elbow function at follow-up. Zero indicating minimal satisfaction, and 100 indicating maximal satisfaction.

    Measured: 12 months

  6. Subjective pain on a scale from 0 (no pain) to 100.

    An individual pain assessment will be recorded using a visual analogue scale (VAS) of elbow pain at follow-up. Zero indicating no pain, and 100 indicating maximal pain.

    Measured: 12 months

  7. Complications

    The patient charts will be reviewed for reports of neurological deficiencies, and an examination of neurologic function will be performed at follow-up. Scar problems, infections, non- and mal-unions and hardware issues will also be reviewed and reexamined. The definition of infection is:

    1. Less serious infection: Superficial wound infection with sign of skin inflammation and/or positive bacterial culture, without the need for secondary surgery, i.e. surgical debridement.
    2. Serious infection: Any postoperative wound infection or sign of deep infection that require secondary surgery.

    Measured: 12 months

  8. Hardware removal

    Rates of planned and performed hardware removal.

    Measured: 12 months

  9. Radiographic evaluation

    Radiographs and computer tomographic (CT) scan will be obtained pre- and postoperatively for optimal classification. Radiographs will also be obtained at six weeks, 3 months, and 12 months. Plain x-rays will include true antero-posterior and lateral projections. The fracture pattern will be classified according to the Mayo classification and Schatzker classification. All radiographs will be reviewed and classified by two senior orthopedic trauma surgeons. Assessment of union and non-union will be assessed and recorded. Displacement of the fracture fragments is to be registered in millimeters at the level of the joint. The joint congruency following surgery and at the following radiographs will be evaluated. Osteoarthritis will be classified according to the system of Broberg and Morrey. Heterotopic ossification will be classified according to Hastings and Graham.

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Sep 2017
  2. Study start1 Dec 2017
  3. Primary completion1 Sep 2022
  4. Study completion1 Sep 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
200 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03280602
Sponsor's protocol ID
2017/671
Status last verified
Nov 2024
First submitted
9 Sep 2017
Last updated
12 Nov 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Duckworth AD, Clement ND, White TO, Court-Brown CM, McQueen MM. Plate Versus Tension-Band Wire Fixation for Olecranon Fractures: A Prospective Randomized Trial. J Bone Joint Surg Am. 2017 Aug 2;99(15):1261-1273. doi: 10.2106/JBJS.16.00773.

    PubMed 28763412
  • Hume MC, Wiss DA. Olecranon fractures. A clinical and radiographic comparison of tension band wiring and plate fixation. Clin Orthop Relat Res. 1992 Dec;(285):229-35.

    PubMed 1446443
  • Buijze G, Kloen P. Clinical evaluation of locking compression plate fixation for comminuted olecranon fractures. J Bone Joint Surg Am. 2009 Oct;91(10):2416-20. doi: 10.2106/JBJS.H.01419.

    PubMed 19797577
  • Chalidis BE, Sachinis NC, Samoladas EP, Dimitriou CG, Pournaras JD. Is tension band wiring technique the "gold standard" for the treatment of olecranon fractures? A long term functional outcome study. J Orthop Surg Res. 2008 Feb 22;3:9. doi: 10.1186/1749-799X-3-9.

    PubMed 18294381
  • Duckworth AD, Clement ND, Aitken SA, Court-Brown CM, McQueen MM. The epidemiology of fractures of the proximal ulna. Injury. 2012 Mar;43(3):343-6. doi: 10.1016/j.injury.2011.10.017. Epub 2011 Nov 9.

    PubMed 22077988
  • Baecher N, Edwards S. Olecranon fractures. J Hand Surg Am. 2013 Mar;38(3):593-604. doi: 10.1016/j.jhsa.2012.12.036.

    PubMed 23428192
  • Edwards SG, Martin BD, Fu RH, Gill JM, Nezhad MK, Orr JA, Ferrucci AM, Love JM, Booth R, Singer A, Hsieh AH. Comparison of olecranon plate fixation in osteoporotic bone: do current technologies and designs make a difference? J Orthop Trauma. 2011 May;25(5):306-11. doi: 10.1097/BOT.0b013e3181f22465.

    PubMed 21464739
  • Karlsson MK, Hasserius R, Karlsson C, Besjakov J, Josefsson PO. Fractures of the olecranon: a 15- to 25-year followup of 73 patients. Clin Orthop Relat Res. 2002 Oct;(403):205-12.

    PubMed 12360028
  • Matar HE, Ali AA, Buckley S, Garlick NI, Atkinson HD. Surgical interventions for treating fractures of the olecranon in adults. Cochrane Database Syst Rev. 2014 Nov 26;2014(11):CD010144. doi: 10.1002/14651858.CD010144.pub2.

    PubMed 25426876
  • Rommens PM, Kuchle R, Schneider RU, Reuter M. Olecranon fractures in adults: factors influencing outcome. Injury. 2004 Nov;35(11):1149-57. doi: 10.1016/j.injury.2003.12.002.

    PubMed 15488508
  • Snoddy MC, Lang MF, An TJ, Mitchell PM, Grantham WJ, Hooe BS, Kay HF, Bhatia R, Thakore RV, Evans JM, Obremskey WT, Sethi MK. Olecranon fractures: factors influencing re-operation. Int Orthop. 2014 Aug;38(8):1711-6. doi: 10.1007/s00264-014-2378-y. Epub 2014 Jun 4.

    PubMed 24893946
  • Tarallo L, Mugnai R, Adani R, Capra F, Zambianchi F, Catani F. Simple and comminuted displaced olecranon fractures: a clinical comparison between tension band wiring and plate fixation techniques. Arch Orthop Trauma Surg. 2014 Aug;134(8):1107-14. doi: 10.1007/s00402-014-2021-9. Epub 2014 Jun 17.

    PubMed 24935660
  • Wagner FC, Konstantinidis L, Hohloch N, Hohloch L, Suedkamp NP, Reising K. Biomechanical evaluation of two innovative locking implants for comminuted olecranon fractures under high-cycle loading conditions. Injury. 2015;46(6):985-9. doi: 10.1016/j.injury.2015.02.010. Epub 2015 Feb 18.

    PubMed 25771445
  • Gruszka D, Arand C, Nowak T, Dietz SO, Wagner D, Rommens P. Olecranon tension plating or olecranon tension band wiring? A comparative biomechanical study. Int Orthop. 2015 May;39(5):955-60. doi: 10.1007/s00264-015-2703-0. Epub 2015 Feb 25.

    PubMed 25711396
  • Wilson J, Bajwa A, Kamath V, Rangan A. Biomechanical comparison of interfragmentary compression in transverse fractures of the olecranon. J Bone Joint Surg Br. 2011 Feb;93(2):245-50. doi: 10.1302/0301-620X.93B2.24613.

    PubMed 21282766

Questions about this trial

What is this clinical trial studying?

A study testing Tension band wiring (TBW) and Plate fixation in people with Olecranon Fracture, run by Oslo University Hospital at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The Quick Disability of the Arm, Shoulder and Hand Outcome Measure (QuickDASH) (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03280602, which also lists 15 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Nov 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in